The FDA's Office of Prescription Drug Promotion will conduct a study on what attributes drive consumer and physician drug choices and how they weigh the trade-offs for diabetes and psoriasis treatment.
Just two months after nabbing a promotion at Merck & Co., the company’s global human health marketing head is hitting the exit to join mRNA vanguard Moderna.
Sol-Gel Technologies’ work to expand the treatment options for patients with the skin condition rosacea has paid off, with the FDA approving a product based on its microencapsulation technology. Galderma will commercialize the topical medicine, Epsolay, in the U.S.
Roche delivered a double-digit sales increase in the first quarter, but CEO Severin Schwan still thinks the company’s full-year haul may come in flat versus 2021.